Compares Chinese medicine and standard care for asthma in adults
Follows adults with asthma treated with Chinese medicine or standard Western medicine alone.
Plain-language title generated from the registry record
Registry title: REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
Key facts
- Where
- Zhengzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06373692, who can take part
Where in China
- The First Affiliated Hospital of Henan University of Traditional Chinese MedicineZhengzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Henan University of Traditional Chinese Medicine
- Trial code
- NCT06373692
- Record updated
- 18 April 2024
- Original description
The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma.Read full original descriptionShow less
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma.
Inclusion: Patients who meet the diagnosis of bronchial asthma; Age 18~80 years old; Have not participated in other clinical studies within 1 month before enrollment; Voluntarily participate in the study and sign the informed consent form.
Exclusion: Patients with respiratory failure and mechanical ventilation during acute asthma exacerbation; Delirium, impaired consciousness, dementia, and various mental illnesses; Patients with other lung diseases such as COPD, lung abscess, cystic fibrosis, bronchiectasis, etc., and severe liver and kidney diseases; Patients with neuromuscular diseases that affect respiratory motor function and are unable to complete the six-minute walk test; Pregnant and lactating patients; Those who are participating in other clinical trials.